2024
426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease
Denoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.Peer-Reviewed Original Research
2023
Antihypertensives in Pregnancy
Denoble A, Goldstein S, Pettker C. Antihypertensives in Pregnancy. Obstetrics And Gynecology Clinics Of North America 2023, 50: 39-78. PMID: 36822710, DOI: 10.1016/j.ogc.2022.10.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSignificant maternal morbidityTreatment of hypertensionAmniotic fluid volumeHypertensive disordersMaternal morbidityPregnant patientsFetal growthCurrent guidelinesEfficacy dataAvailable safetyPregnancyAntihypertensivesFluid volumeClose supervisionHypertensionMorbidityPatientsPostpartumMortalityAvailable dataDiagnosis
2022
Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations
Denoble A, Goldstein S, Grotegut C, Federspiel J. Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s77. DOI: 10.1016/j.ajog.2021.11.146.Peer-Reviewed Original ResearchImpact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizations
Denoble A, Federspiel J, Goldstein S, Grotegut C. Impact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s469-s470. DOI: 10.1016/j.ajog.2021.11.778.Peer-Reviewed Original Research
2021
734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy
DeNoble A, Federspiel J, Wein L, Goldstein S, Grotegut C. 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy. American Journal Of Obstetrics And Gynecology 2021, 224: s460-s461. DOI: 10.1016/j.ajog.2020.12.757.Peer-Reviewed Original Research
2020
Using the new definition of intraamniotic infection – is there morbidity among the women left out?
Smith MM, Daifotis HA, DeNoble AE, Dotters-Katz SK. Using the new definition of intraamniotic infection – is there morbidity among the women left out? The Journal Of Maternal-Fetal & Neonatal Medicine 2020, 34: 4148-4152. PMID: 31928262, DOI: 10.1080/14767058.2020.1711723.Peer-Reviewed Original ResearchConceptsPostpartum infectionIntraamniotic infectionPrimary outcomePostpartum infectious morbidityUrinary tract infectionSingle academic centerFourth-degree lacerationsBackward stepwise eliminationACOG criteriaAntibiotic receiptGestational hypertensionIntrapartum characteristicsMaternal feverMaternal tachycardiaDegree lacerationsInfectious morbidityRetrospective cohortTract infectionsDiagnostic criteriaAcademic centersInfectionWomenBivariate statisticsMorbidityFever
2019
Chorioamnionitis versus intraamniotic infection among preterm deliveries: is postpartum infectious morbidity different?
DeNoble A, Mitchell C, Hughes B, Dotters-Katz S. Chorioamnionitis versus intraamniotic infection among preterm deliveries: is postpartum infectious morbidity different? American Journal Of Obstetrics And Gynecology 2019, 221: 666-667. DOI: 10.1016/j.ajog.2019.10.073.Peer-Reviewed Original ResearchSpiking in the Second Stage: What are the Neonatal Implications? [19D]
Daifotis H, Smith M, Denoble A, Dotters-Katz S. Spiking in the Second Stage: What are the Neonatal Implications? [19D]. Obstetrics And Gynecology 2019, 133: 47s-46s. DOI: 10.1097/01.aog.0000558975.44644.1a.Peer-Reviewed Original ResearchSevere neonatal morbidityLength of stayNeonatal morbidityMaternal feverNICU admissionUntreated womenTerm singleton vaginal deliveriesInvasive respiratory supportSingleton vaginal deliveriesAntepartum complicationsAntibiotic receiptNeonatal implicationsPostnatal antibioticsACOG guidelinesRespiratory supportRetrospective cohortInfectious signsPrimary outcomeSevere morbidityVaginal deliveryMaternal treatmentUntreated groupMorbidityIRB approvalNeonatesUsing the New Definition of Intraamniotic Infection: Is There Morbidity in the Women Left Out? [27D]
Smith M, Daifotis H, Denoble A, Dotters-Katz S. Using the New Definition of Intraamniotic Infection: Is There Morbidity in the Women Left Out? [27D]. Obstetrics And Gynecology 2019, 133: 50s-48s. DOI: 10.1097/01.aog.0000558983.61677.1d.Peer-Reviewed Original ResearchPostpartum infectious morbidityIntraamniotic infectionUrinary tract infectionInfectious morbidityPrimary outcomeSingle academic centerBackward stepwise eliminationAntibiotic receiptGestational hypertensionIntrapartum characteristicsMaternal feverMaternal tachycardiaDegree lacerationsRetrospective cohortTract infectionsAmerican CollegeDiagnostic criteriaAcademic centersIRB approvalMorbidityMore symptomsInfectionWomenBivariate statisticsChorioamnionitis